BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 24050028)

  • 1. Influence of FSHR diplotypes on ovarian response to standard gonadotropin stimulation for IVF/ICSI.
    Lazaros L; Hatzi E; Xita N; Takenaka A; Sofikitis N; Zikopoulos K; Georgiou I
    J Reprod Med; 2013; 58(9-10):395-401. PubMed ID: 24050028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of follicle-stimulating hormone receptor (FSHR) -29 and Ser680Asn polymorphisms in IVF/ICSI.
    Paschalidou C; Anagnostou E; Mavrogianni D; Raouasnte R; Klimis N; Drakakis P; Loutradis D
    Horm Mol Biol Clin Investig; 2020 Mar; 41(2):. PubMed ID: 32114522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
    Huang X; Li L; Hong L; Zhou W; Shi H; Zhang H; Zhang Z; Sun X; Du J
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):577-83. PubMed ID: 25132286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of allelic combinations of FSHR gene polymorphisms with ovarian response.
    Desai SS; Achrekar SK; Paranjape SR; Desai SK; Mangoli VS; Mahale SD
    Reprod Biomed Online; 2013 Oct; 27(4):400-6. PubMed ID: 23953588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor ovarian response to gonadotropin stimulation is associated with low expression of follicle-stimulating hormone receptor in granulosa cells.
    Cai J; Lou HY; Dong MY; Lu XE; Zhu YM; Gao HJ; Huang HF
    Fertil Steril; 2007 Jun; 87(6):1350-6. PubMed ID: 17296182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Ala307Thr polymorphism of the follicle-stimulating hormone receptor (FSHR) gene is associated with the dose of recombinant FSH received during IVF/ICSI treatment.
    Dieamant F; Petersen CG; Vagnini LD; Petersen B; Ricci J; Nicoletti A; Zamara C; Oliani AH; Oliveira JBA; Franco JG
    JBRA Assist Reprod; 2023 Mar; 27(1):78-84. PubMed ID: 36995260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ovarian response to standard gonadotrophin stimulation depends on FSHR, SHBG and CYP19 gene synergism.
    Lazaros LA; Hatzi EG; Pamporaki CE; Sakaloglou PI; Xita NV; Markoula SI; Stefos TI; Zikopoulos KA; Georgiou IA
    J Assist Reprod Genet; 2012 Nov; 29(11):1185-91. PubMed ID: 22915343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FSH receptor genotype does not predict metaphase-II oocyte output or fertilization rates in ICSI patients.
    Mohiyiddeen L; Newman WG; Cerra C; Horne G; Mulugeta B; Byers H; Roberts SA; Nardo LG
    Reprod Biomed Online; 2013 Sep; 27(3):305-9. PubMed ID: 23876973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ovarian response to standard gonadotropin stimulation is influenced by AMHRII genotypes.
    Lazaros L; Fotaki A; Pamporaki C; Hatzi E; Kitsou C; Zikopoulos A; Virgiliou C; Kosmas I; Bouba I; Stefos T; Theodoridis G; Georgiou I
    Gynecol Endocrinol; 2016 Aug; 32(8):641-645. PubMed ID: 26933946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synchronization of ovarian stimulation with follicle wave emergence in patients undergoing in vitro fertilization with a prior suboptimal response: a randomized, controlled trial.
    Baerwald A; Anderson P; Yuzpe A; Case A; Fluker M
    Fertil Steril; 2012 Oct; 98(4):881-7.e1-2. PubMed ID: 22819187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment.
    Peñarrubia J; Fábregues F; Manau D; Creus M; Casals G; Casamitjana R; Carmona F; Vanrell JA; Balasch J
    Hum Reprod; 2005 Apr; 20(4):915-22. PubMed ID: 15665015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is inversely correlated with a mature oocyte yield and can predict "low responders".
    Ho JY; Guu HF; Yi YC; Chen MJ; Ho ES
    Fertil Steril; 2005 Apr; 83(4):883-8. PubMed ID: 15820795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
    Elgindy EA; El-Haieg DO; El-Sebaey A
    Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and follicular dynamics of corifollitropin alfa versus recombinant FSH during ovarian stimulation for IVF.
    Fauser BC; Alper MM; Ledger W; Schoolcraft WB; Zandvliet A; Mannaerts BM;
    Reprod Biomed Online; 2010 Nov; 21(5):593-601. PubMed ID: 20843746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms influence the ovarian response to rFSH stimulation in patients undergoing in vitro fertilization programs with ICSI.
    Boudjenah R; Molina-Gomes D; Torre A; Bergere M; Bailly M; Boitrelle F; Taieb S; Wainer R; Benahmed M; de Mazancourt P; Selva J; Vialard F
    PLoS One; 2012; 7(6):e38700. PubMed ID: 22701696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant gonadotrophins associated with GnRH antagonist (cetrorelix) in ovarian stimulation for ICSI: comparison of r-FSH alone and in combination with r-LH.
    Levi-Setti PE; Cavagna M; Bulletti C
    Eur J Obstet Gynecol Reprod Biol; 2006 Jun; 126(2):212-6. PubMed ID: 16377062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between FSH receptor polymorphism status and IVF cycle outcome: a retrospective observational study.
    König TE; van der Lee J; Schats R; Lambalk CB
    Reprod Biomed Online; 2019 Aug; 39(2):231-240. PubMed ID: 31279715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive factors for ovarian response in a corifollitropin alfa/GnRH antagonist protocol for controlled ovarian stimulation in IVF/ICSI cycles.
    Oehninger S; Nelson SM; Verweij P; Stegmann BJ
    Reprod Biol Endocrinol; 2015 Oct; 13():117. PubMed ID: 26520396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of FSHR variants and antimüllerian hormone in infertility patients with a reduced ovarian response to gonadotropin stimulation.
    Binder H; Strick R; Zaherdoust O; Dittrich R; Hamori M; Beckmann MW; Oppelt PG
    Fertil Steril; 2012 May; 97(5):1169-75.e1. PubMed ID: 22401810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.